Biomarkers of Prognosis and Efficacy of Anti-angiogenic Therapy in Metastatic Clear Cell Renal Cancer

In the last decades, the prognosis of metastatic renal cell carcinoma (mRCC) has remarkably improved following the advent of the “targeted therapy” era. The expanding knowledge on the prominent role played by angiogenesis in RCC pathogenesis has led to approval of multiple anti-angiogenic agents suc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: D'Aniello, Carmine, Berretta, Massimiliano, Cavaliere, Carla, Rossetti, Sabrina, Facchini, Bianca Arianna, Iovane, Gelsomina, Mollo, Giovanna, Capasso, Mariagrazia, Pepa, Chiara Della, Pesce, Laura, D'Errico, Davide, Buonerba, Carlo, Di Lorenzo, Giuseppe, Pisconti, Salvatore, De Vita, Ferdinando, Facchini, Gaetano
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2019
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6917607/
https://ncbi.nlm.nih.gov/pubmed/31921657
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.01400
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados